最近最经典中文mv字幕-最近韩国电影免费高清hd-最近的中文字幕大全免费-最近日韩中文字幕中文翻译歌词

您好,歡迎來到上海士研管理咨詢有限公司
產(chǎn)業(yè)峰會(huì) 演講局 專家智庫服務(wù) 峰會(huì)活動(dòng)服務(wù) 整合營銷服務(wù)
  • 產(chǎn)業(yè)峰會(huì):
    以專業(yè)團(tuán)隊(duì)對產(chǎn)業(yè)和市場客觀詳實(shí)地調(diào)研為前提,擁有戰(zhàn)略性、系統(tǒng)性、全球性的基因,匯集了領(lǐng)導(dǎo)者關(guān)注的熱點(diǎn)話題與領(lǐng)袖代表,為您提供“一站式”的對話、分享、社交平臺(tái)!
  • 演講局:
    致力于為全球企業(yè)和機(jī)構(gòu)提供主題演講家、高管大師班、董事會(huì)顧問,每項(xiàng)服務(wù)都提供了一種更深入、更具互動(dòng)性的體驗(yàn),尤其是針對較小的精選受眾和關(guān)鍵個(gè)人。我們擁有最具影響力的商業(yè)領(lǐng)袖和頂級專家的資源,他們是各自領(lǐng)域的最杰出的代表。我們的團(tuán)隊(duì)由經(jīng)驗(yàn)豐富的演講和活動(dòng)經(jīng)理組成,我們注重建立長期而深入的伙伴關(guān)系。
  • 專家智庫服務(wù):
    中國領(lǐng)先的行業(yè)專家知識信息服務(wù)供應(yīng)商,為需要專業(yè)洞見的商業(yè)決策者匹配具有一手經(jīng)驗(yàn)的行業(yè)專家,助力他們以更加明確的目標(biāo)和堅(jiān)定的信心做出決策。我們有60萬余名專家顧問遍布二十多個(gè)行業(yè),而且每天還在增加!
  • 峰會(huì)活動(dòng)服務(wù):
    致力于成為全球最專業(yè)的產(chǎn)業(yè)峰會(huì)活動(dòng)提供商,為企業(yè)和機(jī)構(gòu)的產(chǎn)業(yè)性峰會(huì)活動(dòng)提供一站式專業(yè)服務(wù),包括調(diào)研策劃、定制邀請、營銷推廣、運(yùn)營組織、項(xiàng)目管理、直播與數(shù)字化會(huì)議等,每項(xiàng)服務(wù)都由經(jīng)驗(yàn)豐富的專業(yè)團(tuán)隊(duì)匹配長期沉淀的產(chǎn)業(yè)資源予以卓越執(zhí)行,我們注重建立長期而深入的伙伴關(guān)系。
  • 整合營銷服務(wù):
    致力于成為全球領(lǐng)先的2B營銷服務(wù)機(jī)構(gòu),聚焦產(chǎn)業(yè)高端活動(dòng)、內(nèi)容、渠道的建設(shè)與沉淀,為客戶提供一站式整合營銷解決方案,助力企業(yè)線上線下獲客與品牌筑造。我們深信專業(yè)團(tuán)隊(duì)匹配產(chǎn)業(yè)資源帶來卓越執(zhí)行,我們注重建立長期而深入的伙伴關(guān)系。
會(huì)議贊助商
4
2026 - 01 - 26
點(diǎn)擊次數(shù):
斯邁旭生物成立于2022年10月,創(chuàng)始人為清華大學(xué)饒燏教授,公司最早在全球開展了“單分子雙靶”靶向蛋白降解(PROTAC)藥物的開發(fā),并率先在國內(nèi)開展了抗體偶聯(lián)降解劑(DAC)平臺(tái)的建立和相關(guān)藥物的研發(fā)。公司管線主要聚焦于自免及腫瘤領(lǐng)域,定位于BIC及FIC,致力于解決難成藥靶點(diǎn)及目前未被滿足的迫切臨床需求的挑戰(zhàn)。斯邁旭于2024年12月獲頒《北京市專精特新中小企業(yè)》,并于2026年1月與清華大學(xué)聯(lián)合獲批蛋白降解與分子膠藥物北京重點(diǎn)實(shí)驗(yàn)室。 SmashBio was founded in October 2022 by Professor Rao Yu from Tsinghua University. The company pioneered the development of "single-molecule dual-target" targeted protein degradation (PROTAC) drugs globally and was the first in China to establish an antibody-conjugated degrader (DAC) platform and conduct related drug R&D. Its pipeline primarily focuses on autoimmune diseases and oncology, aiming for Best-in-Class (BIC) and First-in-Class (FIC) status, dedicated to overcoming challenges associated with undruggable targets and addressing urgent unmet clinical needs.In December 2024, SmashBio was recognized as a "Beijing Specialized, Refined, Unique, and Innovative Small and Medium Enterprise". Furthermore, in January 2026, it jointly established the "Beijing Key Laboratory for Protein Degradation and Molecular Glue Drugs" with Tsinghua University.
5
2026 - 01 - 27
點(diǎn)擊次數(shù):
太倉沿江臨滬,地處長三角核心,1小時(shí)車程可達(dá)上海張江藥谷與蘇州BioBAY。六條鐵路在此交匯,高鐵20余分鐘抵上海虹橋,未來30分鐘至上海東站。生物醫(yī)藥作為太倉市戰(zhàn)略性產(chǎn)業(yè),已集聚昭衍、康乃德等600余家企業(yè),形成完整產(chǎn)業(yè)鏈,年?duì)I收超300億元。太倉港為長江外貿(mào)第一大港,兼具化妝品進(jìn)出口資質(zhì),2024年化妝品進(jìn)口額占江蘇省超60%,寶潔、漢高等龍頭企業(yè)在此扎根。Taicang is strategically located along the Yangtze River and adjacent to Shanghai, at the heart of the Yangtze River Delta. It is within a one-hour drive of Shanghai’s Zhangjiang Pharma Valley and Suzhou BioBAY. Six major railway lines converge here, with high-speed rail providing access to Shanghai Hongqiao Station in just over 20 minutes and to Shanghai East Station in 30 minutes in the near future.Biomedicine has been established as a strategic industry in Taicang, attracting over 600 enterprises such as Joinn Laboratories and Connect Biopharmaceuticals. A complete industrial chain has taken shape, generating annual revenue exceeding RMB 30 billion.Taicang Port, the leading foreign trade port along the Yangtze River, is also licensed for cosmetics import and export. In 2024, its cosmetics imports accounted for more than 60% of Jiangsu Province’s total, with global leaders including P&G and Henkel having established a presence in the city.
6
2026 - 01 - 27
點(diǎn)擊次數(shù):
杭州霆科生物是一家專注于開發(fā)并量產(chǎn)微流控芯片與生命科學(xué)儀器的技術(shù)平臺(tái)型公司。公司定位為“微流控系統(tǒng)研發(fā)制造整體解決方案提供商(CDMO)”,依托于全鏈條的微流控技術(shù)平臺(tái),為醫(yī)療體外診斷(IVD)、藥物篩選(類器官、器官芯片)、微針/微球/納米顆粒制備、化工合成、單細(xì)胞分析、食安/環(huán)保檢測等行業(yè)提供專業(yè)及全面的微流控產(chǎn)品設(shè)計(jì)開發(fā)與生產(chǎn)制造整體解決方案。Tinkerbio is a technology platform company dedicated to the R&D and mass production of microfluidic chips and life science instruments. Positioned as a total solution provider (CDMO) for microfluidic system R&D and manufacturing, the company leverages its full-chain microfluidic technology platform to offer professional, comprehensive end-to-end solutions-encompassing design, development, and manufacturing of microfluidic products-for industries including IVD, drug screening (organoids, organ-on-a-chip), microneedle/microsphere/nanoparticle preparation, chemical synthesis, single-cell analysis, and food safety/environmental testing.官網(wǎng)鏈接:http://www.tinkerbio.com/
微信公眾號
領(lǐng)導(dǎo)者網(wǎng)絡(luò)APP
Copyright ?2005 - 2017上海士研管理咨詢有限公司
犀牛云提供企業(yè)云服務(wù)